Alex H. Chang

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Jing Pan, Jieyu Yang, Biping Deng et al. · Leukemia · 2017 · 235 citations

Medicine, Hematology, Oncology +14

Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study

Jing Pan, Kaiting Tang, Yuechen Luo et al. · The Lancet Oncology · 2023 · 65 citations

Life Sciences, Hematology, Oncology +16

Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial

Dian Zhou, Qian Sun, Jieyun Xia et al. · The Lancet Haematology · 2024 · 50 citations

Life Sciences, Hematology, Immunology +14

Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma

Qiqi Zhang, Cheng Zu, Ruirui Jing et al. · Frontiers in Immunology · 2023 · 25 citations · Full text

Medicine, Immunology, Oncology +16

Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

Yuan Meng, Biping Deng, Rong Luan et al. · Frontiers in Oncology · 2021 · 24 citations · Full text

Medicine, Hematology, Immunology +15